FDA ephedra appeal
This article was originally published in The Tan Sheet
Executive Summary
FDA is expected to submit an opening brief in mid-August to appeal a Utah court's April decision to overturn the agency's ephedra ban. A notice of appeal was filed by FDA in 10th Circuit Court of Appeals June 13 and a court docket opened for the appeal indicates initial filings are due July 7. The Utah court ruled that plaintiff Nutraceutical Corp. could continue selling its product containing 10 mg of ephedra (1"The Tan Sheet" April 18, 2005, p. 5)...
You may also be interested in...
Utah Court Overturns Ephedra Ban For Low-Dose Products
A Utah federal court has barred FDA from enforcing its ban on ephedra products containing 10 mg or less of ephedrine alkaloids per daily dose
Lack Of Industry Involvement In Scoping Process Exacerbates ‘Unworkable’ Timelines
Scientific advice could help companies make up for the lack of involvement in scoping, but slots are in short supply.
Cosmetic And Personal Care Trademark Review: 16 April
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.